Managing the Cost of Inhalers | PRAXIS - COPD Foundation

Jun 18, 2024 · This post was written by: Jonnie Korinko, MSRC, RRT, RRT-ACCS. Three pharmaceutical companies have agreed to cap out-of-pocket costs to $35 in the U.S. The trend began on Thursday, March 7, 2024, when Boehringer Ingelheim, a pharmaceutical company …

CouponFollow Extension

$35
OFF

Managing The Cost Of Inhalers | PRAXIS - COPD Foundation

1 week from now

copdfoundation.org

$6000
OFF

Creating Financial Wellness While Living With Chronic Illness

1 week from now

May 28, 2024 · According to the National Association of Chronic Disease Directors, average annual healthcare costs when living with a chronic condition can easily climb above $6,000 per …

copdfoundation.org

FAQs about Managing the Cost of Inhalers | PRAXIS - COPD Foundation Coupon?

Are inhalers a 'great news' for people with chronic obstructive pulmonary disease (COPD)?

Purvi Parikh, MD, an allergist with Allergy & Asthma Network, told Verywell Health that this is "great news" for people with asthma and chronic obstructive pulmonary disease (COPD). “Many patients, including my own, cannot afford their inhalers despite having health insurance due to exorbitant costs,” Parikh said. ...

Are pharmaceutical companies capping the price of inhalers?

Three major pharmaceutical companies have announced price caps for their inhalers. The inhalers treat patients with asthma and COPD. Changes were made in response to pressure from lawmakers. Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. ...

Do HCPs teach patients with COPD to use inhaler devices?

Although fewer than half of all HCPs assessed the ability to use the device in every patient with newly diagnosed COPD as previously stated, the majority (88%) reported educating their patients with COPD on proper inhaler device use. Individualized one-on-one training was reported by most HCPs overall (81%) but less often by PCPs (67%). ...

What are the most common impediments to using an inhaler?

Most patients (79%) reported experiencing 1 or more physical issues that could impact their ability to correctly manipulate an inhaler device, and 58% identified 2 or 3 impediments. Patients reported arthritis, difficulty with fine motor activities, and poor eyesight as the most common potential impediments to device use ( Table 4 ). ...

When do inhaler price caps start?

The price caps start on June 1, 2024, Boehringer Ingelheim said. If you use an inhaler for asthma or COPD, it may soon become more affordable. If your go-to inhaler isn’t impacted by the out-of-pocket price cap, talk to your healthcare provider. They may be able to recommend an alternative that is under the price cap. ...

Are pharmaceutical companies capping out-of-pocket inhalers at $35?

Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. GlaxoSmithKline (GSK) is the latest company to announce a price cap this month, following the lead of AstraZeneca and Boehringer Ingelheim, who revealed their inhaler price ceilings in March. ...